期刊
CYTOKINE & GROWTH FACTOR REVIEWS
卷 15, 期 5, 页码 379-391出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2004.06.002
关键词
oncostatin M; signal transduction; central nervous system; brain tumors; glial cells
资金
- NCI NIH HHS [CA-97247] Funding Source: Medline
- NIMH NIH HHS [MH-63650] Funding Source: Medline
- NINDS NIH HHS [NS-39954] Funding Source: Medline
Oncostatin M (OSM), a member of the interleukin-6 (IL-6) cytokine family, has yet to be well studied, especially in the context of the central nervous system (CNS). The biological functions of OSM are complex and variable, depending on the cellular microenvironment. Inflammatory responses and tumor development are among two of the major events that OSM is involved in. Although OSM levels remain low in the normal CNS. elevated expression occurs in pathological conditions. Therefore, it is crucial to understand the regulation of OSM to control its expression and/or its effects. Accumulating data demonstrate that OSM binds to specific receptor complexes, then activates two major signaling pathways: Janus Kinase-Signal Transducers and Activators of Transcription (JAK-STAT) and Mitogen-Activated Protein Kinase (MAPK), to regulate downstream events. In this review, we focus on the biological functions of OSM, the signaling pathways of OSM in the CNS. and OSM involvement in CNS diseases. (C) 2004, Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据